Lactobacillus rhamnosus HN001 and Reduced Prevalence of Gestational Diabetes Mellitus

Doses used in studies

CFU single-dose: 6 billion (median 6 billion, IQR 6 billion–6 billion) — 1 study

1 of 1 paper

Effect of Lactobacillus rhamnosus Probiotic in Early Pregnancy on Plasma Conjugated Bile Acids in a Randomised Controlled Trial

2021-01-13
RCT · n = 348
Nutrients 13(1)
- Yutao Chen
- Jun Lu
- K. Wickens
- T. Stanley
- Robyn M. Maude
- P. Stone
- C. Barthow
- J. Crane
- E. Mitchell
- F. Merien
- R. Murphy

PubMed: 33450885
DOI: 10.3390/nu13010209

7 Insights on

Reduced Prevalence of Gestational Diabetes Mellitus

High evidence
Large Human Trial

We have previously shown that probiotic supplementation with *Lactobacillus rhamnosus* HN001 (HN001) led to a reduced incidence of gestational diabetes mellitus (GDM).

Effect: Beneficial
Effect size: Moderate
Significant: Yes